Related Experiment Videos
[A study of the natural evolution of hypertrophic obstructive cardiomyopathy. Analysis of 100 cases (authors'
Insights
Hypertrophic obstructive cardiomyopathy (CIO) progresses slowly, with stable symptoms and a low annual mortality rate. Early identification and treatment of arrhythmias are crucial for improving prognosis in these patients.
Area of Science:
- Cardiology
- Internal Medicine
Context:
- Hypertrophic obstructive cardiomyopathy (CIO) is a significant cardiovascular condition.
- Understanding the long-term course of CIO is essential for patient management.
Purpose:
- To analyze the clinical course and long-term outcomes of 100 patients diagnosed with hypertrophic obstructive cardiomyopathy (CIO).
Summary:
- The study followed 100 patients with CIO (diagnosed non-invasively and invasively) for an average of 8.2 years.
- Symptoms often begin before age 40, with diagnosis and observation typically occurring between ages 20-50.
- Key findings include slow disease evolution, symptom stability, a low annual mortality rate (1.8%), and a high 10-year survival rate.
Impact:
- Results suggest CIO is a slowly evolving condition with a favorable long-term outlook.
- Sudden death is the most frequent cause of mortality, highlighting the importance of identifying and treating arrhythmias for improved prognosis.
Abstract:
The authors present a study of the course of hypertrophic obstructive cardiomyopathy (C.I.O.), diagnosed both through noninvasive (52) and invasive (48 cases) techniques, in 100 patients. The average period of observation (prospective and retrospective) was 8.2 years; in 68 cases prospective inquiries were carried out over an average period of 4.6 years. In 80% of the cases the first symptoms occurred when the patient was under 40, while the first diagnosis and period of observation usually took place between the ages of 20 and 50. The results of this study confirm that CIO is an illness with a slow evolution; the following facts emerge: a) considerable stability of the symptoms; b) low yearly mortality rate (1.8%); c) high rate of survival 10 years after the first onset of the symptoms. The most frequent cause of death is usually sudden, which leads to the supposition that one of the most important elements for prognosis is the identification and treatment of arrhythmias.